Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study

José Cuenca, Cris Glazebrook, Tim Kendall, Tammy Hedderly, Isobel Heyman, Georgina Jackson, Tara Murphy, Hugh Rickards, Mary Robertson, Jeremy Stern, Penny Trayner, Chris Hollis, José Cuenca, Cris Glazebrook, Tim Kendall, Tammy Hedderly, Isobel Heyman, Georgina Jackson, Tara Murphy, Hugh Rickards, Mary Robertson, Jeremy Stern, Penny Trayner, Chris Hollis

Abstract

Background: Tourette syndrome (TS) among young people is associated with psychosocial difficulties and parents play an important role in the management of the condition. Clinical guidelines have been developed for the treatment of TS and tics, but little is known about how young people and their parents perceive their treatment options or their desired outcomes of treatment. The aim of this study is to explore perceptions of treatments for tics among young people with TS and their parents.

Methods: In-depth interviews with 42 young people with TS and a mixed-methods, online survey of 295 parents of young people with TS. Participant recruitment was conducted through Tourettes Action (TA): a non-profit UK organisation for the support of people with TS. Interview transcripts were analysed using thematic analysis and responses to survey open-ended questions were analysed using content analysis. Triangulation of qualitative and quantitative data from the parents' survey and qualitative data from the interviews with young people was used to increase the validity and depth of the findings.

Results: A strong theme was the perception that health professionals have limited knowledge of TS and its treatment. Medication was a common treatment for tics and both young people and parents described benefits of medication. However, adverse effects were frequently described and these were a common reason for stopping medication among young people. Aripiprazole was viewed most positively. Access to behavioural interventions for tics was limited and 76% of parents wanted this treatment to be available for their child. Some young people had reservations about the effectiveness or practicality of behavioural interventions. Reduction and abolition of tics were desired outcomes of treatment, but both parents and young people also identified the importance of increasing control over tics and reducing anxiety-related symptoms. For young people, managing the urge to tic was an important outcome of treatment.

Conclusions: The results suggest a need for more training in the identification and management of TS and wider availability of behavioural treatments. Clinical trials could explore the effectiveness of Aripiprazole used in combination with psycho-educational interventions to reduce anxiety and promote a sense of control.

References

    1. Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008;65:461–72. doi: 10.1016/j.jpsychores.2008.03.006.
    1. Ludolph A, Roessner V, Münchau A, Müller-Vahl K. Tourette syndrome and other tic disorders in childhood, adolescence and adulthood. Dtsch Arztebl Int. 2012;109:821–8.
    1. Conelea CA, Woods DW, Zinner SH, Budman C, Murphy T, Scahill LD, et al. Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey. Child Psychiatry Hum Dev. 2011;42:219–42. doi: 10.1007/s10578-010-0211-4.
    1. Cutler D, Murphy T, Gilmour J, Heyman I. The quality of life of young people with Tourette syndrome. Child Care Health Dev. 2009;35:496–504. doi: 10.1111/j.1365-2214.2009.00983.x.
    1. Debes N, Hjalgrim H, Skov L. The presence of attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder worsen psychosocial and educational problems in Tourette syndrome. J Child Neurol. 2010;25:171–81. doi: 10.1177/0883073809336215.
    1. Lee M-Y, Chen Y-C, Wang H-S, Chen D-R. Parenting stress and related factors in parents of children with Tourette syndrome. J Nurs Res. 2007;15:165–73. doi: 10.1097/01.JNR.0000387612.85897.9a.
    1. Robinson LR, Bitsko RH, Schieve LA, Visser SN. Tourette syndrome, parenting aggravation, and the contribution of co-occurring conditions among a nationally representative sample. Disabil Health J. 2013;6:26–35. doi: 10.1016/j.dhjo.2012.10.002.
    1. Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011;20:173–96. doi: 10.1007/s00787-011-0163-7.
    1. Bornstein RA, Stefl ME, Hammond L. A survey of Tourette syndrome patients and their families: the 1987 Ohio Tourette Survey. J Neuropsychiatry Clin Neurosci. 1990;2:275–81. doi: 10.1176/jnp.2.3.275.
    1. Woods DW, Conelea CA, Himle MB. Behavior therapy for Tourette’s disorder: utilization in a community sample and an emerging area of practice for psychologists. Prof Psychol Res Pr. 2010;41:518–25. doi: 10.1037/a0021709.
    1. Rickards H, Cavanna AE, Worrall R. Treatment practices in Tourette syndrome: the European perspective. Eur J Paediatr Neurol. 2012;16:361–4. doi: 10.1016/j.ejpn.2011.12.001.
    1. Pringsheim T, Doja A, Gorman D, McKinlay D, Day L, Billinghurst L, et al. Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry. 2012;57:133–43.
    1. Verdellen C, Van de Griendt J, Hartmann A, Murphy T, ESSTS Guidelines Group European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011;20:197–207. doi: 10.1007/s00787-011-0167-3.
    1. Scahill L, Woods DW, Himle MB, Peterson AL, Wilhelm S, Piacentini JC, et al. Current controversies on the role of behavior therapy in Tourette syndrome. Mov Disord. 2013;28:1179–83. doi: 10.1002/mds.25488.
    1. Steeves T, McKinlay BD, Gorman D, Billinghurst L, Day L, Carroll A, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57:144–51.
    1. Leckman JF. Tic disorders. BMJ. 2012;344:d7659. doi: 10.1136/bmj.d7659.
    1. Mol Debes NMM, Hjalgrim H, Skov L. Limited knowledge of Tourette syndrome causes delay in diagnosis. Neuropediatrics. 2008;39:101–5. doi: 10.1055/s-2008-1081457.
    1. Rivera-Navarro J, Cubo E, Almazán J. The diagnosis of Tourette’s Syndrome: communication and impact. Clin Child Psychol Psychiatry. 2009;14:13–23. doi: 10.1177/1359104508100127.
    1. Kompoliti K, Goetz CG, Morrissey M, Leurgans S. Gilles de la Tourette syndrome: patient’s knowledge and concern of adverse effects. Mov Disord. 2006;21:248–52. doi: 10.1002/mds.20680.
    1. Tourettes Action.
    1. Parker G, Beresford B, Clarke S, Gridley K, Pitman R, Spiers G, et al. Technical Report for SCIE Research Review on the Prevalence and Incidence of Parental Mental Health Problems and the Detection, Screening and Reporting of Parental Mental Health Problems. York: Social Policy Research Unit, University of York; 2008.
    1. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566–73. doi: 10.1097/00004583-198907000-00015.
    1. Woods DW, Piacentini JC, Chang SW, Deckersbach T, Ginsburg GS, Peterson AL, et al. Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults (Therapist Guide) New York: Oxford University Press; 2008.
    1. O’Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341:1147–50.
    1. Clark JP. How to peer review a qualitative manuscript. In: Godlee F, Jefferson T, editors. Peer Review in Health Sciences. 2. London: BMJ Books; 2003. pp. 219–35.
    1. IBM Corp . IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM; 2010.
    1. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88. doi: 10.1177/1049732305276687.
    1. Boyatzis RE. Transforming Qualitative Information: Thematic Analysis and Code Development. London: Sage; 1998.
    1. Marcks BA, Woods DW, Teng EJ, Twohig MP. What do those who know, know? Investigating providers’ knowledge about Tourette’s syndrome and its treatment. Cogn Behav Pract. 2004;11:298–305. doi: 10.1016/S1077-7229(04)80044-0.
    1. Chilvers R, Stein S, Chowdhury U. Tourette’s: 20 CAMHS cases. Community Pract. 2010;83:38–9.
    1. Yoo HK, Lee J-S, Paik K-W, Choi S-H, Yoon SJ, Kim JE, et al. Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. Eur Child Adolesc Psychiatry. 2011;20:127–35. doi: 10.1007/s00787-010-0154-0.
    1. Yoo HK, Joung YS, Lee JS, Song DH, Lee YS, Kim JW, et al. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette’s disorder. J Clin Psychiatry. 2013;74:e772–80. doi: 10.4088/JCP.12m08189.
    1. Verdellen CWJ, Keijsers GPJ, Cath DC, Hoogduin CAL. Exposure with response prevention versus habit reversal in Tourettes’s syndrome: A controlled study. Behav Res Ther. 2004;42:501–11. doi: 10.1016/S0005-7967(03)00154-2.
    1. Bitsko RH, Danielson M, King M, Visser SN, Scahill L, Perou R. Health care needs of children with Tourette syndrome. J Child Neurol. 2012;12:1626–36.
    1. Wile DJ, Pringsheim TM. Behavior therapy for Tourette syndrome: a systematic review and meta-analysis. Curr Treat Options Neurol. 2013;15:385–95. doi: 10.1007/s11940-013-0238-5.
    1. Himle MB, Freitag M, Walther M, Franklin SA, Ely L, Woods DW. A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders. Behav Res Ther. 2012;50:565–70. doi: 10.1016/j.brat.2012.05.009.
    1. Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette’s syndrome: a review. J Psychosom Res. 2008;65:487–96. doi: 10.1016/j.jpsychores.2008.04.010.
    1. Verdellen CWJ, Hoogduin CAL, Kato BS, Keijsers GPJ, Cath DC, Hoijtink HB. Habituation of premonitory sensations during exposure and response prevention treatment in Tourette’s syndrome. Behav Modif. 2008;32:215–27. doi: 10.1177/0145445507309020.
    1. Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012;47:77–90. doi: 10.1016/j.pediatrneurol.2012.05.002.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren